The document discusses property-based molecular design and some challenges in drug discovery. It notes that molecular design aims to control compound behavior through manipulation of molecular properties in a hypothesis-driven or prediction-driven manner. However, toxicity can be unpredictable and measuring free drug concentrations in vivo is difficult. The document also discusses using structural relationships between compounds as a framework for molecular design and analysis of activity and properties, and notes that both hypothesis-driven and prediction-driven approaches have limitations that require further consideration.